Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Sulfadiazine

A sulfonamide antibiotic, approved in the United States in 1941: it blocks folic acid production in bacteria and, together with pyrimethamine, is the treatment of choice for toxoplasmosis. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?It also has a laboratory use: in plant research it is used to select and maintain genetically modified cells.

SulfadiazineGo to the active ingredient →
SulfadiazineActive ingredientSulfadiazineCat. No. P-S102-001CAS 68-35-9

EDQM standards 4

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.